Compare OPK & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | MFA |
|---|---|---|
| Founded | 2007 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 976.0M |
| IPO Year | 1995 | N/A |
| Metric | OPK | MFA |
|---|---|---|
| Price | $1.29 | $9.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $2.28 | ★ $10.96 |
| AVG Volume (30 Days) | ★ 3.2M | 1.0M |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 14.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.86 |
| Revenue | ★ $642,067,000.00 | $279,011,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.18 |
| P/E Ratio | ★ N/A | $11.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $7.85 |
| 52 Week High | $2.04 | $11.08 |
| Indicator | OPK | MFA |
|---|---|---|
| Relative Strength Index (RSI) | 39.62 | 55.94 |
| Support Level | $1.29 | $9.66 |
| Resistance Level | $1.37 | $9.88 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 10.06 | 56.98 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.